Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003
Published online before print October 9, 2003, doi: 10.1161/01.RES.0000099889.35340.6F
A more recent version of this article appeared on November 14, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/10/917    most recent
01.RES.0000099889.35340.6Fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foster, D. B.
Right arrow Articles by Van Eyk, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foster, D. B.
Right arrow Articles by Van Eyk, J. E.
Related Collections
Right arrow Contractile function
Right arrow Other heart failure

Submitted on October 28, 2002
Revised on September 18, 2003
Accepted on September 25, 2003

C-Terminal Truncation of Cardiac Troponin I Causes Divergent Effects on ATPase and Force. Implications for the Pathophysiology of Myocardial Stunning

D. Brian Foster ; Teruo Noguchi ; Peter VanBuren ; Anne Murphy ; and Jennifer E. Van Eyk *

From the Department of Biochemistry (D.B.F., J.E.V.E.), Queen’s University, Kingston, Ontario, Canada; Cardiology Unit (T.N., P.V.), Department of Medicine, University of Vermont, Burlington, Vt; Department of Pediatrics (A.M.), Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Md; and Department of Physiology (J.E.V.E.), Queen’s University, Kingston, Ontario, Canada. Present address for D.B.F. is Boston Biomedical Research Institute, Watertown, Mass.

* To whom correspondence should be addressed. E-mail: jve1{at}post.queensu.ca.

Myocardial stunning is a form of reversible myocardial ischemia/reperfusion injury associated with systolic and diastolic contractile dysfunction. In the isolated rat heart model, myocardial stunning is characterized by the specific C-terminal proteolysis of the myofilament protein, troponin I (cTnI) that yields cTnI1-193. To determine the effect of this particular C-terminal truncation of cTnI, without the confounding factor of other stunning-induced protein modifications, a series of solution biochemical assays has been undertaken using the human homologue of mouse/rat cTnI1-193, cTnI1-192. Affinity chromatography and actin sedimentation experiments detected little, or no, difference between the binding of cTnI (cTnI1-209) and cTnI1-192 to actin-tropomyosin, troponin T, or troponin C. Both cTnI and cTnI1-192 inhibit the actin-tropomyosin-activated ATPase activity of myosin subfragment 1 (S1), and this inhibition is released by troponin C in the presence of Ca2+. However, cTnI1-192, when reconstituted as part of the troponin complex (cTn1-192), caused a 54±11% increase in the maximum Ca2+-activated actin-tropomyosin-S1 ATPase activity, compared with troponin reconstituted with cTnI (cTn). Furthermore, cTn1-192 increased Ca2+ sensitivity of both the actin-tropomyosin-activated S1 ATPase activity and the Ca2+-dependent sliding velocity of reconstituted thin filaments, in an in vitro motility assay, compared with cTn. In an in vitro force assay, the actin-tropomyosin filaments bearing cTn1-192 developed only 76±4% (P<0.001) of the force obtained with filaments composed of reconstituted cTn. We suggest that cTnI proteolysis may contribute to the pathophysiology of myocardial stunning by altering the Ca2+ sensing and chemomechanical properties of the myofilaments.


Key words: troponin • myocardial stunning • force-ATPase relation • heart failure




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
Y. Lecarpentier, N. Vignier, P. Oliviero, A. Guellich, L. Carrier, and C. Coirault
Cardiac Myosin-Binding Protein C Modulates the Tuning of the Molecular Motor in the Heart
Biophys. J., July 15, 2008; 95(2): 720 - 728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Du, J. Liu, H.-Z. Feng, M. M. Hossain, N. Gobara, C. Zhang, Y. Li, P.-Y. Jean-Charles, J.-P. Jin, and X.-P. Huang
Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2604 - H2613.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tachampa, T. Kobayashi, H. Wang, A. F. Martin, B. J. Biesiadecki, R. J. Solaro, and P. P. de Tombe
Increased Cross-bridge Cycling Kinetics after Exchange of C-terminal Truncated Troponin I in Skinned Rat Cardiac Muscle
J. Biol. Chem., May 30, 2008; 283(22): 15114 - 15121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. S. Rao, L. R. La Bonte, Y. Xu, Z. Yang, B. A. French, and W. H. Guilford
Alterations to myofibrillar protein function in nonischemic regions of the heart early after myocardial infarction
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H654 - H659.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. A. Narolska, N. Piroddi, A. Belus, N. M. Boontje, B. Scellini, S. Deppermann, R. Zaremba, R. J. Musters, C. dos Remedios, K. Jaquet, et al.
Impaired Diastolic Function After Exchange of Endogenous Troponin I With C-Terminal Truncated Troponin I in Human Cardiac Muscle
Circ. Res., October 27, 2006; 99(9): 1012 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. Nedelkov, U. A. Kiernan, E. E. Niederkofler, K. A. Tubbs, and R. W. Nelson
Population Proteomics: The Concept, Attributes, and Potential for Cancer Biomarker Research
Mol. Cell. Proteomics, October 1, 2006; 5(10): 1811 - 1818.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kobayashi and R. J. Solaro
Increased Ca2+ Affinity of Cardiac Thin Filaments Reconstituted with Cardiomyopathy-related Mutant Cardiac Troponin I
J. Biol. Chem., May 12, 2006; 281(19): 13471 - 13477.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. D. Gao, T. Dai, and D. Nyhan
Increased cross-bridge cycling rate in stunned myocardium
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H886 - H893.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. G. Duncan, R. Ravi, L. B. Stull, and A. M. Murphy
Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1512 - H1518.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. R Eberli
Stunned myocardium--an unfinished puzzle
Cardiovasc Res, August 1, 2004; 63(2): 189 - 191.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. G. Soergel, D. Georgakopoulos, L. B. Stull, D. A. Kass, and A. M. Murphy
Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1785 - H1792.
[Abstract] [Full Text] [PDF]